A large team of researchers affiliated with a host of institutions across the U.S. has developed a monoclonal antibody proven to be effective against malaria, perhaps for as long as six months, in a clinical trial. They have ...
Malaria is the deadliest mosquito-borne parasitic infection of humans. In 2021, after a century of research, the World Health Organization (WHO) approved the world's first malaria vaccine. That vaccine reduces the incidence ...
Jul 19, 2022
1
82
Each year, about half a million children in Africa die from malaria. Infection with the malaria parasite is such a widespread and deadly disease that scientists all over the globe are working to understand it better in order ...
Nov 12, 2021
0
137
Griffith University researchers are a step closer in the fight against malaria with the development of a broad-spectrum vaccine that can be freeze-dried making it suitable for deployment into malaria-endemic countries.
Oct 21, 2021
0
86
Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites. ...
Jun 30, 2021
0
7
Scientists from the Walter Reed Army Institute of Research and Naval Medical Research Center partnered with researchers at the University of Pennsylvania and Acuitas Therapeutics to develop a novel vaccine based on mRNA technology ...
Jun 18, 2021
0
1721
A faster method for collecting pure malaria parasites from infected mosquitos could accelerate the development of new, more potent malaria vaccines.
Jun 17, 2021
0
8
At the University Hospital of Tübingen, a clinical trial led by Prof. Dr. Peter Kremsner, Director of the Institute of Tropical Medicine, Travel Medicine and Human Parasitology and Dr. Rolf Fendel, Research Group Leader ...
May 5, 2021
0
47
A change in the plan of attack against malaria—to target the infection as soon as it enters the bloodstream—has yielded exciting results for Burnet Institute scientists seeking to accelerate the development of a highly ...
Mar 31, 2021
1
71
In an unprecedented first, scientists at Seattle Children's Research Institute have developed a genetically attenuated parasite (GAP) that arrests late in the liver stage of human malaria. Their findings published in JCI ...
Jun 16, 2020
0
113
